These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 5722169)

  • 1. Lack of cross-tolerance in rats among (-)delta9-trans-tetrahydrocannabinol(delta9-THC), cannabis extract, mescaline and lysergic acid diethylamide (LSD-25).
    Teresa M; Silva A; Carlini EA; Claussen U; Korte F
    Psychopharmacologia; 1968; 13(4):332-40. PubMed ID: 5722169
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological and behavioral components of tolerance to LSD and mescaline in rats.
    Murray TF; Craigmill AL; Fischer GJ
    Pharmacol Biochem Behav; 1977 Sep; 7(3):239-44. PubMed ID: 928480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysergic acid diethylamide- and mescaline-induced attenuation of the effect of punishment in the rat.
    Schoenfeld RI
    Science; 1976 May; 192(4241):801-3. PubMed ID: 1063447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance to a behavioral effect of lysergic acid diethylamide and cross-tolerance to mescaline in the rat: absence of a metabolic component.
    Winter JC
    J Pharmacol Exp Ther; 1971 Sep; 178(3):625-30. PubMed ID: 5571911
    [No Abstract]   [Full Text] [Related]  

  • 5. Mescaline and lysergic acid diethylamide (LSD) as discriminative stimuli.
    Hirschhorn ID; Winter JC
    Psychopharmacologia; 1971; 22(1):64-71. PubMed ID: 5119576
    [No Abstract]   [Full Text] [Related]  

  • 6. Patterns of tolerance to lysergic acid diethylamide and mescaline in rats.
    FREEDMAN DX; AGHAJANIAN GK; ORNITZ EM
    Science; 1958 May; 127(3307):1173-4. PubMed ID: 13555858
    [No Abstract]   [Full Text] [Related]  

  • 7. Tolerance and cross-tolerance among psychotomimetic drugs.
    Appel JB; Freedman DX
    Psychopharmacologia; 1968 Sep; 13(3):267-74. PubMed ID: 5679628
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of l-delta9- and l-delta8-trans-tetrahydrocannabinol and cannabinol on schedule-controlled behavior of pigeons and rats.
    Frankenheim JM; McMillan DE; Harris LS
    J Pharmacol Exp Ther; 1971 Jul; 178(1):241-52. PubMed ID: 5087402
    [No Abstract]   [Full Text] [Related]  

  • 9. Cumulative alterations in rat behavior during continuous administration of LSD or mescaline: absence of tolerance?
    Ellison G; Ring M; Ross D; Axelrood B
    Biol Psychiatry; 1980 Feb; 15(1):95-102. PubMed ID: 7357060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facilitation of avoidance behaviour by LSD-25 and mescaline in hamsters.
    Sansone M; Castellano C; Messeri P
    Pharmacol Res Commun; 1974 Aug; 6(4):369-76. PubMed ID: 4438404
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of LSD-25 with (-)-delta-9-trans-tetrahydrocannabinol (THC) and attempted cross tolerance between LSD and THC.
    Isbell H; Jasinski DR
    Psychopharmacologia; 1969; 14(2):115-23. PubMed ID: 5350620
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influence of mescaline and of lysergic acid diethylamide (LSD-25) on the development of primary and secondary conditioned avoidance reflexes in rats].
    MAFFII G
    Farmaco Sci; 1959 Jul; 14():503-15. PubMed ID: 13853753
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of mescaline and lysergic acid diethylamide on flicker discrimination in the rat.
    Schechter MD; Winter JC
    J Pharmacol Exp Ther; 1971 May; 177(2):461-7. PubMed ID: 5568801
    [No Abstract]   [Full Text] [Related]  

  • 14. Behavioural effects of some derivatives of amphetamine and LSD and their significance.
    Smythies JR; Beaton J; Benington F; Morin RD
    Nature; 1970 May; 226(5246):644-5. PubMed ID: 5444927
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of 9 -THC, LSD-25 and scopolamine on non-spatial single alternation performance in the runway.
    Miller LL; Drew WG; Wikler A
    Psychopharmacologia; 1973; 28(1):1-11. PubMed ID: 4714677
    [No Abstract]   [Full Text] [Related]  

  • 16. Similarities and differences between mescaline, lysergic acid diethylamide-25 (LSD) and d-amphetamine on various components of fixed interval responding in the rat.
    Tilson HA; Sparber SB
    J Pharmacol Exp Ther; 1973 Feb; 184(2):376-84. PubMed ID: 4688175
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of (--)delta-9-trans-tetrahydrocannabinol in man.
    Isbell H; Gorodetzsky CW; Jasinski D; Claussen U; von Spulak F; Korte F
    Psychopharmacologia; 1967; 11(2):184-8. PubMed ID: 4871478
    [No Abstract]   [Full Text] [Related]  

  • 18. Behavioral tolerance to the effects of LSD in the rat.
    Commissaris RL; Lyness WH; Cordon JJ; Moore KE; Rech RH
    Subst Alcohol Actions Misuse; 1980; 1(2):203-7. PubMed ID: 7302781
    [No Abstract]   [Full Text] [Related]  

  • 19. Environmental influences upon drug-induced suppression of operant behavior.
    Sparber SB; Tilson HA
    J Pharmacol Exp Ther; 1971 Oct; 179(1):1-9. PubMed ID: 5096565
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of delta9-THC, LSD-25 and scopolamine on continuous, spontaneous alternation in the Y-maze.
    Drew WG; Miller LL; Baugh EL
    Psychopharmacologia; 1973; 32(2):171-82. PubMed ID: 4753532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.